Mkt Advisors LLC Pfizer Inc Transaction History

Mkt Advisors LLC

$213 Million
Q3 2024

A detailed history of Mkt Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mkt Advisors LLC holds 20,662 shares of PFE stock, worth $546,096. This represents 0.28% of its overall portfolio holdings.

Number of Shares

20,662

Previous 20,205 2.26%

Holding current value

$546,096

Previous $565,000 5.66%

% of portfolio

0.28%

Previous 0.29%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$27.7 - $31.39 $12,658 - $14,345	457 Added 2.26%	20,662 $597,000
Q2 2024 Jul 12, 2024	SELL	$25.26 - $29.6 $10,205 - $11,958	-404 Reduced 1.96%	20,205 $565,000
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $19,961 - $22,921	-771 Reduced 3.61%	20,609 $571,000
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $26,626 - $34,584	-1,019 Reduced 4.55%	21,380 $615,000
Q3 2023 Oct 12, 2023	SELL	$32.09 - $37.51 $129,868 - $151,802	-4,047 Reduced 15.3%	22,399 $742,000
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $151,342 - $175,100	-4,190 Reduced 13.68%	26,446 $970,000
Q1 2023 Apr 10, 2023	SELL	$39.39 - $51.28 $14,377 - $18,717	-365 Reduced 1.18%	30,636 $1.25 Million
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $7,515 - $9,810	-180 Reduced 0.58%	31,001 $0
Q3 2022 Oct 20, 2022	BUY	$43.76 - $53.42 $17,110 - $20,887	391 Added 1.27%	31,181 $1.36 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $51,555 - $61,128	1,108 Added 3.73%	30,790 $1.61 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $174,948 - $216,782	3,824 Added 14.79%	29,682 $1.44 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $1.07 Million - $1.58 Million	25,858 New	25,858 $1.37 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mkt Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mkt Advisors LLC with notifications on news.

Account